-
ECONOMIC AND CLINICAL OUTCOMES OF CELL-BASED VERSUS EGG-BASED INFLUENZA VACCINES IN U.S. PEDIATRIC AND ADULT POPULATIONS: A MODELING STUDY
Mar 18, 2026, 21:38 PM -
IMPACT OF MEDICATION ADHERENCE ON CLINICAL AND ECONOMIC OUTCOMES IN TYPE 2 DIABETES: A SCOPING REVIEW OF REAL-WORLD EVIDENCE
Mar 18, 2026, 21:38 PM -
AN EXPANDED ANALYSIS OF WHICH FEATURES CONVEY EMPATHY TO PATIENTS IN SCIENTIFIC WRITING
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF FITUSIRAN PROPHYLAXIS VERSUS FACTOR VIII ON-DEMAND OR PROPHYLACTIC THERAPY FOR HEMOPHILIA A PATIENTS WITHOUT INHIBITORS
Mar 18, 2026, 21:38 PM -
INDIRECT TREATMENT COMPARISON OF ODEVIXIBAT AND MARALIXIBAT FOR THE TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS WITH ALAGILLE SYNDROME (ALGS)
Mar 18, 2026, 21:38 PM -
COST-MINIMIZATION ANALYSIS OF DAMOCTOCOG ALFA PEGOL VERSUS EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH SEVERE HEMOPHILIA A WITHOUT INHIBITORS IN COLOMBIA, PERU AND COSTA RICA
Mar 18, 2026, 21:38 PM -
SPENDING ON GENE THERAPIES FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Mar 18, 2026, 21:38 PM -
COMPARATIVE RISK OF SUICIDAL IDEATION AND SELF-HARM AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH BREXPIPRAZOLE VERSUS OTHER ORAL ATYPICAL ANTIPSYCHOTICS: A PROPENSITY SCORE-MATCHED COHORT ANALYSIS
Mar 18, 2026, 21:38 PM -
ASSESSING ACCESS TO INNOVATIVE ORPHAN MEDICINES IN LATIN AMERICA: A CROSS-COUNTRY VALUE AND ACCESS ANALYSIS
Mar 18, 2026, 21:38 PM -
PATIENT-CENTRIC PATHWAYS: SURVEYING TREATMENT ACCESS AND SUPPORT FOR RARE DISEASES, INCLUDING RARE CANCERS, IN EUROPE
Mar 18, 2026, 21:38 PM -
POST-DISCHARGE TREATMENT PATHWAYS AFTER IV THERAPY FOR COMPLICATED UTI INCLUDING ACUTE PYELONEPHRITIS: IMPLICATIONS FOR LENGTH OF STAY, COSTS, AND TREATMENT FAILURE
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF CONSOLIDATION DURVALUMAB VERSUS OSIMERTINIB IN PATIENTS WITH UNRESECTABLE, STAGE III, EGFR-MUTATED NON-SMALL-CELL LUNG CANCER: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
ANTIHYPERTENSIVE TREATMENT PATTERNS BEFORE AND DURING PREGNANCY AMONG WOMEN WITH CHRONIC HYPERTENSION: A REAL-WORLD EHR STUDY
Mar 18, 2026, 21:38 PM -
ADVANCING EQUITY IN PROSTATE CANCER RESEARCH: STRATEGY AND OUTCOMES FROM A PROSPECTIVE ENROLLMENT INITIATIVE
Mar 18, 2026, 21:38 PM -
COMPARING THECOSTEFFECTIVENESS OFONSITEBUPRENORPHINE TREATMENT VERSUSTREATMENT FACILITY REFERRALATHARM REDUCTION AGENCIES
Mar 18, 2026, 21:38 PM -
CLINICAL TRIAL EVIDENCE SUPPORTING FDA APPROVAL OF NOVEL AGENTS IN 2024
Mar 18, 2026, 21:38 PM -
ALIGNMENT OF PATIENT-REPORTED OUTCOME IMPROVEMENTS WITH ICER COST-EFFECTIVENESS AND VALUE-BASED PRICE RECOMMENDATIONS IN RHEUMATOID ARTHRITIS
Mar 18, 2026, 21:38 PM -
BALANCING PRIVACY AND USABILITY IN REAL-WORLD DATA FOR OLDER ADULTS
Mar 18, 2026, 21:38 PM -
THE INCIDENCE OF INTRAUTERINE ADHESIONS FOLLOWING POTENTIALLY ADHESIOGENIC PROCEDURES: A SYSTEMATIC LITERATURE REVIEW WITH META-ANALYSES
Mar 18, 2026, 21:38 PM -
ECONOMIC BURDEN ASSOCIATED WITH SJÖGREN’S DISEASE (SJD): A SYSTEMATIC LITERATURE REVIEW (SLR)
Mar 18, 2026, 21:38 PM
